Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Maryam A. Alharaibi"'
Autor:
Mohammed A. Omair, Tariq Alhawassi, Munira Alwaihibi, Ghada Aldrees, Mahmoud Mosli, Wesam M. Asser, Maryam A. Alharaibi, Atheer T. Alotaibi, Doaa A. Bintaleb, Najah K. Alharbi, Ahmed Z. Alotaibi, Wajed A. Alshammari, Nouf Alanazi, Ali M. Asiri, Rana Almadany, Hanan Al Rayes, Turki Al-Thunian, Moureq Alotaibi, Abdulrazaq Al Jazaeri
Publikováno v:
Saudi Pharmaceutical Journal, Vol 28, Iss 12, Pp 1827-1829 (2020)
The loss of patentability of many originator biologics has led to the rapid introduction of biosimilar agents. The anticipated economic benefit of introducing such agent has been accompanied by vagueness surrounding their biotechnology, approval requ
Externí odkaz:
https://doaj.org/article/18b68d61ece245bfac6ad4bab51d7038
Autor:
Parameaswari P. Jaganathan, Tariq M. Alhawassi, Yousif A. Asiri, Sheraz Ali, Abdullah A. Alhifany, Monira Alwhaibi, Maryam Ali Alharaibi
Publikováno v:
Annals of Saudi Medicine, Vol 41, Iss 3, Pp 147-156 (2021)
Annals of Saudi Medicine
Annals of Saudi Medicine
BACKGROUND: Multiple studies have investigated medication errors in hospitals in Saudi Arabia; however, prevalence data on prescribing errors and associated factors remains uncertain. OBJECTIVE: Assess the prevalence, type, severity, and factors asso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::635e04740f82c49948352f15ec5f3c89
https://doi.org/10.5144/0256-4947.2021.147
https://doi.org/10.5144/0256-4947.2021.147
Autor:
Mahmoud Mosli, Doaa A. Bintaleb, Turki Al-Thunian, Moureq R. Alotaibi, Wajed A. Alshammari, Hanan Al Rayes, Najah K. Alharbi, Ghada A Aldrees, Ali Mohammed Asiri, Rana Almadany, Mohammed A. Omair, Atheer T. Alotaibi, Ahmed Z. Alotaibi, Maryam A. Alharaibi, Munira Alwaihibi, Wesam M. Asser, Abdulrazaq Al Jazaeri, Nouf A. Alanazi, Tariq M. Alhawassi
Publikováno v:
Saudi Pharmaceutical Journal, Vol 28, Iss 12, Pp 1827-1829 (2020)
Saudi Pharmaceutical Journal : SPJ
Saudi Pharmaceutical Journal : SPJ
The loss of patentability of many originator biologics has led to the rapid introduction of biosimilar agents. The anticipated economic benefit of introducing such agent has been accompanied by vagueness surrounding their biotechnology, approval requ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52bfe5fabf8a9ccb347d1630f0fc1bd9
http://www.sciencedirect.com/science/article/pii/S1319016420302693
http://www.sciencedirect.com/science/article/pii/S1319016420302693
Autor:
Maryam Ali Alharaibi, Abdullah A. Alhifany, Yousif A. Asiri, Monira M. Alwhaibi, Sheraz Ali, Parameaswari P. Jaganathan, Tariq M. Alhawassi
Publikováno v:
Annals of Saudi Medicine, Vol 41, Iss 3, Pp 147-156 (2021)
BACKGROUND: Multiple studies have investigated medication errors in hospitals in Saudi Arabia; however, prevalence data on prescribing errors and associated factors remains uncertain. OBJECTIVE: Assess the prevalence, type, severity, and factors asso
Externí odkaz:
https://doaj.org/article/ab02acdaeaa24338904bb7590b9bcbe1